Kurt Wheeler

This profile gathers the share dealings of Kurt Wheeler across 7 companies, led by Somaxon Pharmaceuticals, Inc., Globus Medical Inc and Senorx Inc. In total, 38 filings cover trades dated from 13 February 2007 to 6 January 2016.

In open-market terms, that means 3 purchases worth €6.6M on one side and 17 sales worth €16.5M on the other. Netting one side against the other leaves €9.9M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 5 share grants and 2 option exercises. So far in 2016, the count stands at no purchases and 2 sales.

In size, the median ticket on the buying side is €956k.

Most recently, on 6 January 2016, the filings show an option exercise in Globus Medical Inc. The last insider purchase was made public on 30 November 2010, 5,822 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.